company background image
EZZ

EZZ Life Science HoldingsASX:EZZ Stock Report

Market Cap

AU$21.4m

7D

-4.7%

1Y

n/a

Updated

19 Oct, 2021

Data

Company Financials
EZZ fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends0/6

EZZ Overview

EZZ Life Science Holdings Limited provides skin care and consumer health products to retailers and consumers in Australia, New Zealand, Mainland China, and internationally.

Price History & Performance

Summary of all time highs, changes and price drops for EZZ Life Science Holdings
Historical stock prices
Current Share PriceAU$0.51
52 Week HighAU$0.38
52 Week LowAU$1.43
Beta0
1 Month Change-11.30%
3 Month Change24.39%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-56.03%

Recent News & Updates

Shareholder Returns

EZZAU Retail DistributorsAU Market
7D-4.7%1.1%1.7%
1Yn/a-3.0%20.3%

Return vs Industry: Insufficient data to determine how EZZ performed against the Australian Retail Distributors industry.

Return vs Market: Insufficient data to determine how EZZ performed against the Australian Market.

Price Volatility

Is EZZ's price volatile compared to industry and market?
EZZ volatility
EZZ Beta0
Industry Beta1
Market Beta1

Stable Share Price: EZZ is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: EZZ's weekly volatility (11%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2018n/aQizhou Qinhttps://www.ezzlife.com.au

EZZ Life Science Holdings Limited provides skin care and consumer health products to retailers and consumers in Australia, New Zealand, Mainland China, and internationally. The company operates in two segments, Brought in Lines and Company Owned products. It is involved in the wholesale distribution of EAORON branded skin care products to pharmacies, supermarkets, and specialist retailers, as well as other grocery and on-line retailers.

EZZ Life Science Holdings Fundamentals Summary

How do EZZ Life Science Holdings's earnings and revenue compare to its market cap?
EZZ fundamental statistics
Market CapAU$21.42m
Earnings (TTM)AU$2.03m
Revenue (TTM)AU$22.29m

10.6x

P/E Ratio

1.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
EZZ income statement (TTM)
RevenueAU$22.29m
Cost of RevenueAU$9.83m
Gross ProfitAU$12.46m
ExpensesAU$10.43m
EarningsAU$2.03m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.048
Gross Margin55.90%
Net Profit Margin9.11%
Debt/Equity Ratio0%

How did EZZ perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

8%

Payout Ratio

Valuation

Is EZZ Life Science Holdings undervalued compared to its fair value and its price relative to the market?

10.55x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: EZZ (A$0.51) is trading above our estimate of fair value (A$0.09)

Significantly Below Fair Value: EZZ is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: EZZ's PE Ratio (10.6x) is in line with the Australian Retail Distributors industry average.

PE vs Market: EZZ is good value based on its PE Ratio (10.6x) compared to the Australian market (19.9x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate EZZ's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: EZZ is good value based on its PB Ratio (2.1x) compared to the AU Retail Distributors industry average (2.3x).


Future Growth

How is EZZ Life Science Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

10.3%

Forecasted Retail industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as EZZ Life Science Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has EZZ Life Science Holdings performed over the past 5 years?

28.0%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: EZZ has high quality earnings.

Growing Profit Margin: EZZ's current net profit margins (9.1%) are higher than last year (8.8%).


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if EZZ's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare EZZ's past year earnings growth to its 5-year average.

Earnings vs Industry: EZZ earnings growth over the past year (28%) underperformed the Retail Distributors industry 28.8%.


Return on Equity

High ROE: EZZ's Return on Equity (20.1%) is considered high.


Financial Health

How is EZZ Life Science Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: EZZ's short term assets (A$11.7M) exceed its short term liabilities (A$1.9M).

Long Term Liabilities: EZZ's short term assets (A$11.7M) exceed its long term liabilities (A$1.3K).


Debt to Equity History and Analysis

Debt Level: EZZ is debt free.

Reducing Debt: EZZ has not had any debt for past 5 years.

Debt Coverage: EZZ has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: EZZ has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is EZZ Life Science Holdings's current dividend yield, its reliability and sustainability?

0.88%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: EZZ's dividend (0.88%) isn’t notable compared to the bottom 25% of dividend payers in the Australian market (2.27%).

High Dividend: EZZ's dividend (0.88%) is low compared to the top 25% of dividend payers in the Australian market (5.28%).


Stability and Growth of Payments

Stable Dividend: EZZ is not paying a notable dividend for the Australian market, therefore no need to check if payments are stable.

Growing Dividend: EZZ is not paying a notable dividend for the Australian market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: EZZ is not paying a notable dividend for the Australian market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of EZZ's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.0yrs

Average board tenure


CEO

Qizhou Qin

no data

Tenure

Mr. Mark Qin, is also known as Qizhou, serves as the Chief Operating Officer at EZZ Life Science Holdings Limited and serves as its Executive Director since October 27, 2020. Mr. Qin serves as an Interim C...


Board Members

Experienced Board: EZZ's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: EZZ only recently listed within the past 12 months.


Top Shareholders

Company Information

EZZ Life Science Holdings Limited's employee growth, exchange listings and data sources


Key Information

  • Name: EZZ Life Science Holdings Limited
  • Ticker: EZZ
  • Exchange: ASX
  • Founded: 2018
  • Industry: Distributors
  • Sector: Retail
  • Market Cap: AU$21.420m
  • Shares outstanding: 42.00m
  • Website: https://www.ezzlife.com.au

Location

  • EZZ Life Science Holdings Limited
  • 104 Derby Street
  • Silverwater
  • New South Wales
  • 2128
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/19 07:02
End of Day Share Price2021/10/19 00:00
Earnings2021/06/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.